Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery

Abstract

The content of these European Society of Cardiology (ESC) Guidelines has been published for personal and educational use only. No commercial use is authorized. No part of the ESC Guidelines may be translated or reproduced in any form without written permission from the ESC. Permission can be obtained upon submission of a written request to Oxford University Press, the publisher of the European Heart Journal and the party authorized to handle such permissions on behalf of the ESC.Disclaimer: The ESC Guidelines represent the views of the ESC and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgement. The guidelines do not, however, over-ride the individual responsibility of health professionals to make appropriate decisions in the circumstances of the individual patients, in consultation with that patient, and where appropriate and necessary the patient's guardian or carer. It is also the health professional's responsibility to verify the rules and regulations applicable to drugs and devices at the time of prescription.

Echocardiography Predicts Major Adverse Cardiovascular Events after Renal Transplantation

“…However, we still perform TTE routinely which is contrary to guidelines [2,12]. Despite this, we showed that pre-transplant echocardiograms strongly predicted major clinical events after transplantation.…”

“…Stress echocardiography or myocardial perfusion scans may be recommended [2,3] if the exercise test is positive or equivocal while coronary angiography may be considered if the functional tests show evidence of ischaemia [2]. However, Aalten et al [10] showed no evidence that pre-transplantation revascularisation improved outcome and concluded that cardiac investigation should be reserved for those with significant cardiac symptoms or high cardiac risk and poor exercise capacity as recommended for other types of surgery [11,12]. …”

Impact of the FloTrac/Vigileo^TM Monitoring on Intraoperative Fluid Management and Outcome after Liver Resection

“…Patients with primary and secondary hepatic tumors were included. Patients with preoperative serum creatinine >1.3 mg/dL were excluded, as kidney impairment is an independent risk factor for perioperative adverse events [14]. Based on these criteria, 172 patients in group A and 168 patients in group B were eligible for the study.…”

Antikoaguliantų Ir Antiagregantų Vartojimas Akių Chirurgijoje

“…Amerikos ir Europos širdies asociacijų gairėse nurodoma, kad net ir operacijos metu aspirino vartojimo nutraukti nereikėtų, jei kardiovaskulinių įvykių tikimybė yra ryškiai didesnė nei kraujavimo. Jei reikia, aspirino vartojimą galima nutraukti likus trims dienoms prieš invazinę procedūrą, klopidogrelio ar tikagrelolio vartojimą nutraukti likus penkioms, prasugrelio septynioms dienoms prieš planuojamą intervenciją [9,10].…”